RiceBran Technologies (NASDAQ:RIBT) CEO Brent Robert Rystrom bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 4th. The shares were bought at an average cost of $3.31 per share, for a total transaction of $16,550.00. Following the transaction, the chief executive officer now directly owns 147,777 shares of the company’s stock, valued at approximately $489,141.87. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Brent Robert Rystrom also recently made the following trade(s):
- On Thursday, December 6th, Brent Robert Rystrom bought 5,000 shares of RiceBran Technologies stock. The shares were bought at an average cost of $3.24 per share, for a total transaction of $16,200.00.
Shares of RIBT stock opened at $3.30 on Friday. RiceBran Technologies has a 1 year low of $1.30 and a 1 year high of $3.46.
RiceBran Technologies (NASDAQ:RIBT) last announced its earnings results on Tuesday, November 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.02. RiceBran Technologies had a negative net margin of 74.93% and a negative return on equity of 45.57%. The business had revenue of $3.46 million for the quarter.
A number of hedge funds have recently made changes to their positions in RIBT. BlackRock Inc. increased its position in RiceBran Technologies by 340.2% during the second quarter. BlackRock Inc. now owns 60,264 shares of the company’s stock worth $130,000 after acquiring an additional 46,574 shares during the period. Renaissance Technologies LLC increased its position in RiceBran Technologies by 190.7% during the second quarter. Renaissance Technologies LLC now owns 669,200 shares of the company’s stock worth $1,445,000 after acquiring an additional 439,000 shares during the period. JPMorgan Chase & Co. increased its position in RiceBran Technologies by 253.4% during the third quarter. JPMorgan Chase & Co. now owns 101,860 shares of the company’s stock worth $292,000 after acquiring an additional 73,036 shares during the period. Dimensional Fund Advisors LP bought a new position in RiceBran Technologies during the third quarter worth $345,000. Finally, Royce & Associates LP bought a new position in RiceBran Technologies during the third quarter worth $144,000. 10.71% of the stock is currently owned by institutional investors and hedge funds.
Separately, Lake Street Capital set a $5.00 target price on shares of RiceBran Technologies and gave the stock a “buy” rating in a research report on Wednesday, November 7th.
About RiceBran Technologies
RiceBran Technologies processes and markets healthy, natural, and nutrient dense products derived from raw rice bran. The company manufactures and distributes stabilized rice bran (SRB) in various granulations with other products and derivatives. It offers RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich derivative of RiBalance; and protein and protein/fiber blends under the ProRyza brand.
Read More: How is inflation measured?
Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.